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Liver transplantation in patients with patent 
splenorenal shunts 
Carlos O. Esquivel, M.D., Ph.D., Goran Klintmalm, M.D., Ph.D., 
Shunzaburo Iwatsuki, M.D., Leonard Makowka, M.D., Ph.D., Robert D. Gordon, M.D., 
Andreas Tzakis, M.D., and Thomas E. Starzl, M.D., Ph.D., Pittsburgh, Pa. 
Patent distal splenorenal shunts (Warren shunt) have been reported to cause decreases 
in the portal perfusion pressure and the total hepatic blood flow. Such hemodynamic 
alterations could have adverse effects on the transplanted liver. The experience with 
hepatic replacement in four patients with patent Warren shunts is reported. Operative 
findings were phlebosclerotic portal veins of small size and diminished portal blood 
flows. Hepatofugal collateral channels created by the construction of the Warren shunt 
were eliminated by division of the shunt and splenectomy in three patients and 
splenectomy alone in the other. All patients recovered; thus the presence of a patent 
Warren shunt should not be a contraindication for hepatic transplantation. 
From the Department of Surgery, University of Pittsburgh Health Center, University of 
Pittsburgh, and the Veterans Administration Medical Center, Pittsburgh, Pa. 
DISTAL SPLENORENAL SHUNTS introduced by Warren, 
Zeppa, and Fomon in 1967 have become a popular 
method of therapy in the prevention of recurrent 
gastroesophageal hemorrhage in patients with portal 
hypertension. l The objective of the Warren shunt was 
to selectively decompress the gastroesophageal varices 
while maintaining portal perfusion. l The advantage of 
maintaining the portal perfusion is to prevent compli-
cations such as encephalopathy and hepatic atrophy, 
which have been observed with complete diversion of 
the portal blood flow. 2,3 
Numerous trials have proved the effectiveness of the 
distal splenorenal shunt in preventing hemorrhage 
without an exhorbitant risk of encephalopathy, but the 
progression of liver disease often leads to hepatic 
failure. 4,5 The only recourse in this situation is liver 
transplantation. To date there have been no reports of 
liver replacement after placement of the Warren 
shunts, and the expected difficulties have not been 
delineated. We report our experience with liver trans-
plantation in four patients with patent splenorenal 
shunts and end-stage liver disease. 
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PATIENTS AND METHODS 
Five patients with distal splenorenal shunts were 
among our first 500 consecutive liver transplant recip-
ients. Selective angiography was performed in four 
patients to determine patency of the shunts and quality 
of perfusion of the portal vein. One of these patients 
was not included in this report since thrombosis of the 
shunt with a patent portal vein was demonstrated by 
angiography. Liver transplantation on this particular 
patient was not any different from that of other 
recipients without portosystemic shunts. The patient 
who had no preoperative angiography was found to 
have a patent splenorenal shunt intraoperatively, 
The following parameters were reviewed: age and 
diagnosis, time interval from the creation of the War-
ren shunt to the liver transplant, size and characteris-
tics of the portal vein, blood flow in the portal vein, 
management of the splenorenal shunt, and survival. 
Liver transplantation was performed following tech-
niques previously described." The liver was replaced 
first followed by the splenectomy. The shunt was then 
ligated in three patients. The venovenous bypass was 
used in all patients.7 A cannula was fed into the inferior 
vena cava via the femoral vein, and another cannula 
was inserted into the portal vein, decompressing both 
the systemic and splanchnic systems, respectively. With 
the use of a rollerhead pump, the blood was then 
delivered into the axillary vein via a single cannula. A 
flowmeter placed in this cannula recorded the total 
Volume 107 
Number 4 
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Table I. Liver transplantation in patients with Warren shunts 
Interval from SRS Survival after 
Pt. Age (yr) Sex Diagnosis to OLT (yr) Shunt management GU' (mo) 
1 48 M at-Antitrypsin deficiency 3 Splenectomy and division 13 
2 37 F Primary biliary cirrhosis 5 Splenectomy and division 14 
3 32 M Sclerosing cholangitis Splenectomy 9 
4 29 F Cryptogenic cirrhosis 4 Splenectomy and ligation 7 
IA'gCllri: SRS, Distal splcnorenal shunt; OLT, Orthotopic liver transplantation. 
Table II. Findings in patients with splenorenal shunts and end-stage liver disease 
Preoperative angiography Intraoperative characteristics 
Total byjJass flow of portal vein 
Pt. Portal perfusion Warren shunt m l/m in 
1 Fair Patent 3500 
2 Poor Patent 2000 
3 Poor Patent 2400 
4 2400 
j,cgend' ND, :'\JondelC"ctable, 
blood flow in the bypass (sum of portal vein and vena 
cava blood flows). The blood flow in the portal vein 
was determined in all four patients by subtracting the 
flow of the vena cava from the total blood flow that was 
performed when the portal vein cannula was removed 
for the portal vein reconstruction. 
RESULTS 
Tables I and II summanze the results. In all 
patients, the portal vein was small and thickened by 
what appear to be fibrous plaques. The dissection of 
the hilum was easy since this area was undisturbed 
during previous operations. The flow in the portal vein 
was undetectable in cases 2 through 4 because no 
change was noted in the total blood flow when the 
portal vein cannula was removed. Splenectomy was 
perfonned in all patients without any difficulty; how-
ever, ligation of the shunt in patient 2, approached 
through the lesser sac, was difficult because of the 
presence of large collateral vessels. This patient devel-
oped pancreatitis and formation of a pancreatic fistula 
that resolved with nonoperative management. In cases 
1 and 4, the Warren shunt was approached through the 
mesocolon without any problems, but in case 3, no 
attempt was made to identify the Warren shunt 
because of the presence of dense adhesions. All patients 
are alive and well with nonnal hepatic function. 
DISCUSSION 
The objective of the Warren shunt is to decompress 
the esophageal varices through the short gastric and 
Size (em) Phlebosclerosis Flow ml/min 
1.5 Present 500 
1.2 Present ND 
1.2 Present ND 
1.2 Present ND 
splenic veins via the splenorenal shunt. I. 5 Hemody-
namic studies have shown a decrease in portal perfu-
sion pressure after the construction of a distal spleno-
renal shunt.8 This is partly explained by the elimina-
tion of inflow from the splenic vein that is diverted into 
the vena cava and partly by a "leak" from the 
high-pressure mesenteric venous bed into the decom-
pressed gastrosplenic bed. 
Consequently, a decrease in the total hepatic blood 
flow has been observed in patients with splenorenal 
shunts.8 At the same time, it is known that the Warren 
shunt is a high-flow shunt. Twofold increases in the 
blood flow of the splenic vein have been noted after the 
construction of distal splenorenal shunts.8 Such hemo-
dynamic alterations could have adverse effects on the 
transplanted liver and were the basis for initial concern 
when liver transplants were performed in these 
patients. It was feared that portal blood flow would be 
shunted away from the new liver by the old collaterals. 
The flow determinations of the venovenous bypass of 
our four patients demonstrated the insignificance of the 
contribution by the portal vein to portal perfusion. 
Little or no change in the blood flow was noticed when 
the cannula from the portal vein was removed for the 
portal vein reconstruction. The portal limb of the 
venous bypass was probably unnecessary since the 
splanchnic circulation appeared to be well decom-
pressed via the vena cava. There were consistent 
anatomic changes; the diameter of the portal veins 
measured from 1.2 to 1.5 em, which is smaller than 
that of other adult liver transplant recipients whose 
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portal vein diameter average 2.5 cm. The decrease in 
the portal vein size has been demonstrated angiograph-
ically in patients with splenorenal shunts, and it is 
probably caused by a "steal" that occurs with the 
gradual development of collateral hepatofugal chan-
nels.8 However, the small size of the portal vein and the 
phlebosclerosis observed in all four patients did not 
prevent the reconstruction of good anastomoses of the 
portal vein. 
Because of concerns about the collateral circulation, 
plans were made to remove the venous collaterals 
surgically created by the Warren shunt or caused by its 
construction. Although replacement of the cirrhotic 
liver eliminates portal hypertension, there are condi-
tions after hepatic transplantation that may be associ-
ated with an increased outflow resistance such as 
primary graft nonfunction, rejection, and fluid over-
load. In these situations, the blood flow will probably 
be drained via the .shunt and away from the liver. The 
transplantations were relatively easy since no dissec-
tions had been performed in the hilum. Liver trans-
plantation was performed first and then followed by 
the splenectomy when the patient was stable and the 
preoperative coagulapathy was corrected. Further-
more, the splanchnic circulation was decompressed 
after hepatic replacement, which facilitated the sple-
nectomy and dissection of the shunt. All patients 
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recovered and none had any evidence of complications 
from the portal vein. At the time this article was 
written, all patients were alive and well with normal 
liver function tests. Patency of the portal vein has been 
demonstrated in all patients after surgery by Doppler 
ultrasound. 
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